Imperial Brands Launches £1.45B Buyback Plan as New Product Revenue Jumps 12-14%

Oct.07.2025
Imperial Brands Launches £1.45B Buyback Plan as New Product Revenue Jumps 12-14%
Imperial Brands: FY results in line; launches £1.45bn buyback (to Oct 2026). Constant-currency net revenue to grow low single digits; NGP +12%–14%; adjusted operating profit growth similar to last year’s 4.6%.

Key Takeaways

 

  • Results vs. guidance: Performance for the fiscal year to Sept 30 is in line with the guidance given with the May interim results.

 

  • Buyback size & timeline: New £1.45bn share repurchase to run through October 2026.

 

  • Revenue & profit trends (constant FX): Net revenue for Tobacco + NGP expected to grow at a low single-digit rate; NGP net revenue up 12%–14%; adjusted operating profit growth similar to last year’s 4.6% (previously guided to around the mid-single-digit range).

 

  • Shareholder returns: Next fiscal year’s total returns (buybacks + dividends) expected to exceed £2.7bn.

2Firsts, Oct 7, 2025 — According to a MarketScreener report on Oct 7, Imperial Brands plc (IMB) said its fiscal-year results to Sept 30 are consistent with guidance issued alongside its May interim results. The company also announced a new £1.45bn share buyback to be completed by Oct 2026, and said total shareholder returns (buybacks plus dividends) are expected to top £2.7bn in the next fiscal year.

 

 

Key Operating Details

 

 

Guidance alignment: Management says FY performance matches the May guidance.

 

Revenue (constant FX): Net revenue for Tobacco and “Next-Generation Products” (NGP—e-vapor, heated tobacco, and oral nicotine) is expected to grow at a low single-digit percentage; within that, NGP net revenue is expected to rise 12%–14%.

 

Profit (constant FX): Group adjusted operating profit growth is anticipated to be similar to last year; the FY2024 figure was +4.6%, and prior guidance pointed to “around the midpoint of mid-single-digit” growth.

 

Capital allocation: £1.45bn buyback through Oct 2026; total shareholder returns next fiscal year expected to exceed £2.7bn.

 

As of early London trading (late morning UK time), Imperial Brands was up about +2.7%, among the FTSE 100’s notable gainers.

 

 

Context & View

 

 

Imperial reiterated its dual-track strategy: legacy tobacco provides stable cash flow while NGP maintains low-to-mid-teens growth (12%–14%). The new buyback extends the company’s shareholder-return policy and aligns with its medium-term target for adjusted operating profit growth in the mid-single digits. Note: growth rates, buyback size, and timelines reflect the company’s disclosures today; market pricing is time-sensitive, and intraday figures are not quantified in the report.

 

Image source: MarketScreener.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
BAT Estimates U.S. Unauthorized Vape Market at $9.4 Billion, Plans New Vuse and Velo Launches After FDA Enforcement Shift
British American Tobacco (BAT) CEO Tadeu Marroco said the U.S. unauthorized vape market is worth about £7 billion, or US$9.43 billion. Following a shift in FDA enforcement policy, BAT plans to launch flavored Vuse products in the third quarter and an updated Velo pouch in August or September.
Jun.15
Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
Canadian Court Allows Juul and Altria Vape Class Action to Move Forward Over Youth Marketing Claims
A Quebec Superior Court has allowed a class action lawsuit against Juul Labs and Altria Group related to vaping products to proceed, involving allegations concerning marketing practices, youth exposure and corporate responsibility. The ruling only allows the case to move forward and does not represent a finding that Juul or Altria are legally liable. The case highlights continued legal risks facing vape companies regarding product marketing, youth protection and corporate accountability.
Jul.28
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts Hosts U.S. Compliance Briefing on Building PMTA Support Capabilities Across the Nicotine Supply Chain
2Firsts held a U.S. compliance briefing in Shenzhen to help vaping, heated tobacco and nicotine pouch supply chain companies strengthen PMTA support capabilities. The event focused on supplier documentation, quality systems, traceability, TPMF/TPMP pathways, age verification and customer audit readiness as U.S. compliance expectations increasingly extend deeper into the nicotine supply chain.
Events
Jun.12
Product | VELO Launches Tomorrowland Limited Edition 2026 as Festival IP Enters Nicotine Pouch Packaging
Product | VELO Launches Tomorrowland Limited Edition 2026 as Festival IP Enters Nicotine Pouch Packaging
BAT’s nicotine pouch brand VELO has introduced the Tomorrowland Limited Edition 2026. Public retail-channel information shows the product has appeared across multiple European online platforms, while Haypp UK has listed related SKUs with a “Coming soon” status. The packaging carries the wording “Official Tomorrowland Partner,” indicating that the collection is part of VELO’s official collaboration with the electronic music festival brand.
Jul.02
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
U.S. FDA: Youth E-Cigarette Prevention Campaign Prevented About 444,000 Initiations and Reduced Illegal Vape Sales
The U.S. Food and Drug Administration (FDA) said its youth e-cigarette prevention campaign, “The Real Cost,” prevented about 444,000 U.S. youth from starting e-cigarette use between 2023 and 2024 and blocked more than $42 million in unauthorized e-cigarette sales that would have been used by youth.
Market
Jun.25